A recent report highlights that Chinese innovative drugs have achieved significant milestones, with over 11 new target/mechanism drugs approved in 2025, surpassing last year's total and indicating a strong upward trend. Separately, the challenges of rocket recovery were discussed, with院士赫晓东 emphasizing the advanced state of Chinese heat-insulating materials, which are world-leading. In AI news, Zhipu founder Tang Jie sent an internal memo discussing the importance of 'GLM moments' and future priorities, while a separate report noted Claude's extensive code rewriting, sparking controversy. AI
IMPACT AI's extensive code rewriting capabilities are sparking debate, while Zhipu founder discusses future priorities.
RANK_REASON The cluster contains multiple distinct news items from a single source, including a report on drug approvals, a discussion on rocket technology, and AI news, rather than a single cohesive event.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
